Effect of the Antioxidant Micronutrients of Rapeseed Oil on the Prevention of Cardiovascular Diseases (Optim'Oils)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to assess the effect of optimized oil (enriched with micronutriments) on the prevention on cardiovascular diseases.
Randomised crossover dietary intervention study:
The main objective of the clinical study is to investigate the effect of the consumption of an "optimized" rapeseed oil on the lipid metabolism of volunteers as compared with the consumption of a "reference" oil.
Post prandial study:
The second objective of the clinical study is to investigate the effect of the consumption of an "optimized" rapeseed oil on the biomarkers of oxidative stress during post prandial period as compared with the consumption of a "reference" oil.
| Condition | Intervention |
|---|---|
|
Cardiovascular Diseases |
Dietary Supplement: Rapeseed Oil (prevention of cardiovascular diseases) |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Crossover Assignment Masking: Double Blind (Subject, Investigator) Primary Purpose: Prevention |
| Official Title: | Effect of the Antioxidant Micronutrients of Rapeseed Oil on the Prevention of Cardiovascular Diseases |
- HDL-Cholestérol [ Time Frame: study 1 ] [ Designated as safety issue: Yes ]
- Biomarkers of the oxidative stress every 3 weeks Biomarkers of the oxidative stress during the post prandial period [ Time Frame: every 3 weeks, during the post prandial period ] [ Designated as safety issue: Yes ]
| Estimated Enrollment: | 60 |
| Study Start Date: | December 2008 |
| Study Completion Date: | July 2009 |
| Primary Completion Date: | July 2009 (Final data collection date for primary outcome measure) |
-
Dietary Supplement: Rapeseed Oil (prevention of cardiovascular diseases)
For both studies, sedentary men between 30 and 65 years of age, with a BMI between 25 and 30, without cardiovascular disorders, will be selected.
Randomised crossover dietary intervention study:
Sixty volunteers will be randomised into 2 groups of 30. The study will last 12weeks. The first 3 weeks will be an adaptation period or "run in". Volunteers will have every day20 g of the reference rapeseed oil and 20 g of the reference oil-based rapeseed margarine. Subsequently, the two groups will follow 2 dietary intervention periods of 3 weeks during which the volunteers will have alternatively either the reference oil/margarine or the optimized oil/margarine. Three weeks of "wash out" will separate the two dietary interventions of the cross over design trial.
Cardiovascular risk and oxidative stress biomarkers will be assessed in plasma at week 0, 3, 6, 9 and 12.
Volunteers will alsoperform dietary surveys at the week 3, 6, 9 and 12.
Post prandial study:
16 volunteers will be cast lots among the 60 volunteers. They will be randomised into 2 groups of 8. The first kinetic study will be done on week 3. 8 subjects will take 66 g of reference oil and 8 subjects will take 66 g of the optimized oil. 5 blood samples (20 mL each) will be taken.
Eligibility| Ages Eligible for Study: | 30 Years to 65 Years |
| Genders Eligible for Study: | Male |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Male
- Age : 30 to 65
- Body mass index between 25 and 30 kg/m²
- Weight lower than 110 kg
- Subject considered as normal after clinical examination and medical questionnaire
- Subject giving his written informed consent
- Subject willing to comply with the study procedures
- Affiliated to National Health Insurance
Exclusion Criteria:
- Biological results judged abnormal by investigator
- Positive serologies to HIV or HCV
- Previous medical and/or surgery judged by the investigator as incompatible with the study
- Taking medicine: hypocholesterolemic,beta blockers, IEC,
- Diabetes1 and 2
- High blood pressure
- Digestive, cardiovascular, renal, liver, tumor or thyroid diseases in the last 5 years
- Infectious or inflammatory diseases in the last 5 years
- Previous heavy intestine surgery (except appendectomy)
- Triglycerides> 4 g/L
- Dyslipidemia: HDL cholesterol< 0.4 g/L or LDL/HDL>6.25
- blood donation done less than 2 month before the start of the study
- Particular diet: vegetarian, vegan...
- Anormal dietary habits
- Consumption of food complements: antioxidant, ...
- intense physical exercise practise (>5 h per week)
- Tobacco, alcohol:more than 30 g of alcohol/day, i.e.3 glasses/day, smoking > 5 cigarettes /day
- No affiliated to National Health Insurance people
- Refusal to sign informed consent
- Refusal to be registered on the National Volunteers Data file
- Currently participating or who having got 4500 E in this year before to have participated in another clinical trial
Contacts and Locations| France | |
| CRNH Auvergne | |
| Clermont-Ferrand, France, 63000 | |
| Principal Investigator: | Noël Cano | Centre de Recherche en Nutrition Humaine d'Auvergne |
More Information
No publications provided
| Responsible Party: | Noël CANO, CRNH Auvergne |
| ClinicalTrials.gov Identifier: | NCT00852735 History of Changes |
| Other Study ID Numbers: | CHU-0047, AU 759 |
| Study First Received: | February 26, 2009 |
| Last Updated: | March 9, 2010 |
| Health Authority: | France: Ministry of Health |
Keywords provided by University Hospital, Clermont-Ferrand:
|
Cardiovascular diseases Rapeseed oil Micronutriments HDL cholesterol |
Oxidative stress Tocopherols Sterols Prevention of cardiovascular diseases |
Additional relevant MeSH terms:
|
Cardiovascular Diseases Antioxidants Micronutrients Trace Elements Molecular Mechanisms of Pharmacological Action |
Pharmacologic Actions Protective Agents Physiological Effects of Drugs Growth Substances |
ClinicalTrials.gov processed this record on May 21, 2013